The amount of activating EGFR mutations in circulating cell-free DNA is a marker to monitor osimertinib response.
The amount of activating EGFR mutations in circulating cell-free DNA is a marker to monitor osimertinib response. — المؤلف: Del Re, Marzia — British journal of cancer 20190913
- المؤلف
- Del Re, Marzia
- النشر
- British journal of cancer 20190913
- الوصف
- 1252-1258 p.
- الموضوعات
- Acrylamides؛ Adult؛ Aged؛ Aged, 80 and over؛ Aniline Compounds؛ Antineoplastic Agents؛ Carcinoma, Non-Small-Cell Lung؛ Cell-Free Nucleic Acids